⌘K

Home/Filings/4/0000950170-24-009494

4//SEC Filing

FORD KATHLEEN 4

Accession 0000950170-24-009494

CIK 0001422143other

View on SEC.gov Company Profile

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 5:30 PM ET

Size

4.9 KB

Accession

0000950170-24-009494

Insider Transaction Report

Form 4

Period: 2024-01-29

Kura Oncology, Inc.KURA

Chief Operating Officer

Transactions

Sale
Common Stock
2024-01-29$17.80/sh−1,496$26,630→ 21,602 total

Footnotes (2)

[F1]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.
[F2]Includes 1,884 shares acquired on November 17, 2023 pursuant to the Issuer's Employee Stock Purchase Plan.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Kura Oncology, Inc.

CIK 0001422143

Entity typeother

Related Parties

1

filerCIK 0001785406

Filing Metadata

Form type: 4
Filed: Jan 30, 7:00 PM ET
Accepted: Jan 31, 5:30 PM ET
Size: 4.9 KB

View on SEC.gov